Jaundice (Hemolytic) - Causes, Treatment & When to See a Doctor

```html

What is Jaundice (Hemolytic)?

Jaundice is a yellow discoloration of the skin, sclerae (the whites of the eyes), and mucous membranes caused by an excess of bilirubin in the bloodstream. Hemolytic jaundice specifically results from the rapid breakdown (hemolysis) of red blood cells (RBCs), which releases large amounts of unconjugated (indirect) bilirubin that the liver cannot process quickly enough.

Unlike obstructive (cholestatic) jaundice—where bilirubin can’t leave the liver—and hepatic jaundice—where liver cells are damaged—hemolytic jaundice originates outside the liver. The condition can be acute or chronic and may appear in newborns (physiologic newborn jaundice) or adults with underlying hematologic disorders.

Common Causes

Below are the most frequent conditions that lead to hemolytic jaundice. Some are inherited, while others are acquired or drug‑related.

• Hereditary Spherocytosis – A membrane defect causing fragile, sphere‑shaped RBCs that are destroyed in the spleen.
• G6PD Deficiency – Enzyme deficiency that makes RBCs vulnerable to oxidative stress from foods, infections, or certain medications.
• Sickle Cell Disease – Abnormal hemoglobin (HbS) causes RBCs to sickle, leading to chronic hemolysis.
• Autoimmune Hemolytic Anemia (AIHA) – The body produces antibodies that bind to RBCs, marking them for destruction.
• Thalassemia (α or β) – Ineffective erythropoiesis and premature RBC death produce chronic hemolysis.
• Paroxysmal Nocturnal Hemoglobinuria (PNH) – A clonal stem‑cell disorder that makes RBCs susceptible to complement‑mediated lysis.
• Infections – Malaria, babesiosis, and certain bacterial infections (e.g., Clostridium perfringens) can lyse RBCs.
• Mechanical Destruction – Prosthetic heart valves, extracorporeal circulation (e.g., ECMO), or severe burns can physically damage RBCs.
• Drug‑Induced Hemolysis – Medications such as penicillin, cephalosporins, quinidine, and some antimalarials can trigger immune hemolysis.
• Cold Agglutinin Disease – Autoantibodies that cause RBC clumping in cold temperatures, leading to hemolysis.

Associated Symptoms

Because hemolysis releases hemoglobin and bilirubin while also depleting red‑cell mass, patients often experience a constellation of systemic signs.

• Yellow skin and eyes – Most noticeable on the palms, soles, and sclerae.
• Dark urine – Due to hemoglobin or bilirubin excretion.
• Fatigue, weakness, or shortness of breath – Resulting from anemia.
• Palpitations or rapid heartbeat (tachycardia) – Compensatory response to low hemoglobin.
• Spleen enlargement (splenomegaly) – The spleen works overtime to remove damaged RBCs.
• Abdominal pain – Often from splenic congestion.
• Fever or chills – May accompany an underlying infection or an autoimmune flare.
• Back pain (flank) – Especially in hemoglobinuria from severe intravascular hemolysis.
• Itching (pruritus) – Bile salts deposited in the skin can cause discomfort.

When to See a Doctor

Prompt medical evaluation is essential if you notice any of the following:

• Rapidly worsening yellow color of the skin or eyes.
• Dark (cola‑colored) urine or light‑colored stools.
• Signs of anemia: persistent fatigue, dizziness, rapid heartbeat, or shortness of breath.
• Unexplained fever, chills, or severe abdominal / back pain.
• Sudden swelling of the abdomen or a feeling of fullness.
• History of a recent infection, new medication, or exposure to chemicals/foods that can trigger hemolysis.

Even if symptoms seem mild, individuals with known hemolytic disorders (e.g., sickle cell disease) should contact their hematologist promptly, as early intervention can prevent complications.

Diagnosis

Diagnosing hemolytic jaundice involves confirming both elevated bilirubin and active red‑cell destruction.

Laboratory Tests

• Complete Blood Count (CBC) – Typically shows low hemoglobin/hematocrit and a raised reticulocyte count (young RBCs trying to replace lost cells).
• Peripheral Blood Smear – May reveal spherocytes, schistocytes, sickle cells, or bite cells depending on the cause.
• Serum Bilirubin – Elevated indirect (unconjugated) bilirubin is characteristic of hemolysis.
• Lactate Dehydrogenase (LDH) – Increases when RBCs rupture.
• Haptoglobin – Decreases because it binds free hemoglobin; low levels support intravascular hemolysis.
• Direct Antiglobulin Test (Coombs test) – Detects antibodies or complement bound to RBCs, helping identify autoimmune causes.
• G6PD Enzyme Assay – Required when a G6PD deficiency is suspected.
• Hemoglobin Electrophoresis – Determines abnormal hemoglobin variants (e.g., HbS, HbC, HbE).

Imaging & Other Studies

• Ultrasound of the abdomen – Evaluates spleen size and excludes biliary obstruction.
• Bone Marrow Biopsy – Rarely needed, but may be performed when marrow failure is a concern.
• Genetic Testing – For hereditary conditions such as hereditary spherocytosis or thalassemia.

Diagnostic Criteria

Most clinicians use a combination of the hemolytic index (elevated LDH, low haptoglobin, increased reticulocytes) and bilirubin pattern (predominantly indirect). The underlying cause is then pinpointed with targeted labs (Coombs test, enzyme assays, genetic panels) and clinical history.

Treatment Options

Treatment is two‑pronged: address the immediate bilirubin rise and treat the underlying hemolytic process.

Immediate Management of Jaundice

• Phototherapy – Primarily used in neonates; blue‑light converts indirect bilirubin into water‑soluble forms that can be excreted without liver conjugation.
• Intravenous Immunoglobulin (IVIG) – Helpful in immune‑mediated hemolysis (e.g., warm AIHA) to block Fc receptors and reduce RBC destruction.
• Exchange Transfusion – Reserved for severe neonatal hyperbilirubinemia (>20 mg/dL) or when bilirubin threatens the brain (kernicterus).

Targeted Treatment of the Underlying Cause

• Folic Acid Supplementation – Supports increased RBC production; 1 mg daily is common.
• Corticosteroids (prednisone 1 mg/kg) – First‑line for warm AIHA; taper once hemoglobin stabilizes.
• Rituximab – Anti‑CD20 monoclonal antibody used for steroid‑refractory AIHA or chronic lymphocytic leukemia–associated hemolysis.
• Splenectomy – Considered for hereditary spherocytosis, refractory AIHA, or chronic hemolysis where the spleen is the primary site of RBC removal.
• Hydroxyurea – Reduces sickling crises and hemolysis in sickle cell disease.
• G6PD Avoidance Strategies – Patients must avoid oxidant drugs (e.g., sulfa drugs, quinine) and foods (fava beans).
• Antimicrobial Therapy – Treat underlying infections such as malaria (artemether‑lumefantrine) or bacterial sepsis.
• Complement Inhibitors – Eculizumab is FDA‑approved for PNH and atypical hemolytic uremic syndrome (aHUS).
• Exchange transfusion or simple RBC transfusion – Used when anemia is severe (<7 g/dL) or symptomatic; matched, washed RBCs reduce alloimmunization risk.

Supportive & Home Care Measures

• Stay well‑hydrated to aid renal clearance of hemoglobin.
• Maintain a balanced diet rich in iron (if iron‑deficient), folate, and vitamin B12.
• Avoid alcohol and hepatotoxic drugs, which can further compromise bilirubin processing.
• Monitor urine color; report any sudden darkening.

Prevention Tips

While some hemolytic disorders are genetic and unavoidable, many triggers are modifiable.

• Know your medication list – Inform all providers of any history of drug‑induced hemolysis. Carry a card listing unsafe drugs (e.g., sulfa, dapsone, certain antimalarials).
• Vaccinate against infections – Immunizations for influenza, pneumococcus, and hepatitis reduce infection‑related hemolysis.
• Practice food safety – G6PD‑deficient individuals should avoid fava beans, broad‑bean sprouts, and some mentholated products.
• Use protective measures in cold environments – For cold‑agglutinin disease, keep extremities warm and avoid rapid temperature changes.
• Regular follow‑up – People with chronic hemolytic disorders benefit from routine hematology visits to adjust therapy and screen for complications.
• Screen newborns – Universal newborn bilirubin screening identifies early physiologic jaundice and directs timely phototherapy.
• Avoid unnecessary iron supplementation – Excess iron can promote oxidative stress in certain hemolytic states.
• Maintain a healthy weight – Obesity can exacerbate hepatic congestion, worsening bilirubin clearance.

Emergency Warning Signs

Key Take‑aways

Hemolytic jaundice is a sign that red blood cells are being destroyed faster than the liver can process bilirubin. Recognizing the pattern of yellow discoloration together with anemia‑related symptoms can lead to early diagnosis and targeted treatment. While some causes are genetic, many triggers—medications, infections, temperature extremes—are preventable. Prompt medical evaluation, especially when warning signs appear, helps avoid serious complications such as severe anemia, kidney injury, or bilirubin‑induced brain damage.

References:

• Mayo Clinic. “Jaundice.” Updated 2023. https://www.mayoclinic.org
• National Institute of Hematology, NIH. “Hemolytic Anemia.” 2022. https://www.nhlbi.nih.gov
• Cleveland Clinic. “Autoimmune Hemolytic Anemia.” 2024. https://my.clevelandclinic.org
• World Health Organization. “Guidelines on Management of Neonatal Jaundice.” 2021. https://www.who.int
• American Society of Hematology. “Guidelines for the Management of Sickle Cell Disease.” 2023. https://www.ash.org

```